Bergamot Reduces Plasma Lipids, Atherogenic Small Dense LDL, and Subclinical Atherosclerosis in Subjects with Moderate Hypercholesterolemia: A 6 Months Prospective Study

Background: Some patients experience statin-induced side effects or prefer nutraceutical approaches for the treatment of dyslipidemia. This has led to a search for alternative therapeutic approaches for dyslipidemia management. In recent studies Citrus bergamia (known as Bergamot) juice was able to...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Front Pharmacol
Prif Awduron: Toth, Peter P., Patti, Angelo M., Nikolic, Dragana, Giglio, Rosaria V., Castellino, Giuseppa, Biancucci, Teresa, Geraci, Fabiana, David, Sabrina, Montalto, Giuseppe, Rizvi, Ali, Rizzo, Manfredi
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Frontiers Media S.A. 2016
Pynciau:
Pharmacology
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC4702027/
https://ncbi.nlm.nih.gov/pubmed/26779019
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2015.00299
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg